Abstract
The global response to this severe pandemic disease relies heavily on clinical laboratory testing, which plays a vital role in early diagnosis, treatment, and epidemiological surveillance. Molecular, serological, and biochemical diagnostic methods have been applied in the detection of COVID-19 cases. The RT-PCR-based molecular methods have become the gold standard technique used across the world for COVID-19 confirmatory of infection based on the qualitative detection of the nucleic acids of SARS-CoV-2. However, it might show a false negative result, it can only detect 71% of COVID19 infections depending on the time symptoms appear (viral load) or any sampling error may occur. To prevent possible cross-reaction with other prevalent coronaviruses, the assay should include at least two molecular targets.
Metadata
Item Type: | Monograph (Bulletin) |
---|---|
Creators: | Creators Email / ID Num. UiTM, Faculty of Pharmacy UNSPECIFIED |
Contributors: | Contribution Name Email / ID Num. Editor Abdul Majeed, Prof. Dato' Dr. Abu Bakar UNSPECIFIED |
Subjects: | R Medicine > RS Pharmacy and materia medica > Pharmacopoeias |
Divisions: | Universiti Teknologi MARA, Selangor > Puncak Alam Campus > Faculty of Pharmacy |
Keywords: | Prescription, Newsletter, Faculty of Pharmacy |
Date: | October 2024 |
URI: | https://ir.uitm.edu.my/id/eprint/105638 |